Perrigo’s Global Expectations Counter Slower U.S. OTC Growth
This article was originally published in The Pink Sheet Daily
Executive Summary
The private labeler hopes its international expansion will help mitigate the impact of the return of major branded OTCs from J&J and Novartis to the market.